Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Yahoo Finance · 4 days ago
Open | 763.50 |
High | 763.55 |
Low | 750.53 |
Mkt Cap | 720.12B |
P/E (TTM) | 111.10 |
Div & Yield | 5.20 & 0.69% |
Prev. Close | 760.00 |
52 Wk. Low | 419.80 |
52 Wk. High | 800.78 |
Related stocks
American pharmaceutical company
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 8.77B | 26.00% ▲ |
Net Income | 2.24B | 66.80% ▲ |
Diluted EPS | 2.58 | 66.40% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $2.75 | - |
Q1 2024 | $2.46 | $2.58 |
Q4 2023 | $2.22 | $2.49 |
S&P FuturesES=F | 5,245.75+0.25 (+0.00%) |
Dow FuturesYM=F | 39,566.00+7.00 (+0.02%) |
Nasdaq FuturesNQ=F | 18,286.50-9.00 (-0.05%) |
30.45+74.40% | |
5.19+78.35% | |
3.1000+6.90% |